Abstract:Kunjie Zheng, 1– 3 Xiaolong Li, 1– 3 Yihua Rong, 2 Xuejing Wang, 4 Liping Hou, 2 Wei Gu, 2 Xiaoyu Hou, 3 Yunpeng Guan, 5 Lifang Liu, 6 Jianlin Geng, 2 Guangyao Song 1, 3 1 Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 2 Department of Endocrinology, Hengshui People's Hospital, Hengshui, Hebei, People's Republic of China; 3 Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China; 4 Hengshui People's Hospital Statistical Office, Hengshui, Hebei, People's Republic of China; 5 Department of Endocrinology, Shijiazhuang People's Hospital, Shijiazhuang, Hebei Province, People's Republic of China; 6 Department of Endocrinology, Baoding First Central Hospital, Baoding, Hebei, People's Republic of China Correspondence: Guangyao Song, Department of Endocrinology, Hebei General Hospital, 348 Heping West Road, Shijiazhuang, Hebei, 050051, People's Republic of China, Email Purpose: Elevated serum gamma-glutamyltranspeptidase (GGT) is an independent marker of the activation of systemic inflammation, while conditions associated with elevated triglyceride (TG) levels, such as type 2 diabetes, non-alcoholic fatty liver disease, obesity, and metabolic syndrome, are associated with an increased inflammatory burden. Moreover, serum liver enzymes (GGT, alanine aminotransferase [ALT], aspartate aminotransferase [AST], and alkaline phosphatase [ALP]) are associated with metabolic syndrome and its components, including hypertriglyceridemia. However, the relationship between liver enzymes and postprandial hypertriglyceridemia (PHTG) remains unclear. Therefore, in this study we conducted oral fat tolerance tests (OFTTs) to understand the differences in serum liver enzyme levels among individuals with different lipid tolerance levels and their correlation with PHTG. Patients and Methods: For the OFTT, we enrolled 202 non-diabetic volunteers whose fasting triglyceride (TG) levels were less than 1.7 mmol/L in this case-control study. The participants were categorized into two groups according to the TG levels at the 0- and 4-h OFTT: a postprandial normal TG (PNTG) group and a PHTG group. Routine fasting serum biochemical indices, liver enzyme (GGT, ALT, AST, and ALP) levels, and 0- and 4-h OFTT lipid levels were assessed. Results: The PHTG group had significantly higher serum GGT and ALT levels and a lower AST/ALT ratio than those in the PNTG group. However, no significant difference was observed in AST and ALP levels compared with the PNTG group. After adjusting for major confounders, logistic regression analysis indicated a significant correlation between serum GGT and PHTG (odds ratio = 1.168, P < 0.001), but not with ALT level, AST level, AST/ALT ratio, and ALP level. The receiver operating characteristic curve analysis demonstrated that the serum GGT level was an effective predictor of PHTG. Conclusion: Serum GGT levels are significantly associated with PHTG risk and serve as an effective biomarker for early identification. Keywords: gamma-glutamyl transferase, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, inflammation, triglyceride, oral fat tolerance test With rapid economic development and lifestyle changes, the prevalence of hypertriglyceridemia (HTG) in our country has gradually increased. Dyslipidemia poses a serious threat to human health. Elevated levels of triglyceride (TG)-rich lipoprotein cholesterol have been linked to an increased risk of cardiovascular disease, according to large clinical trials. 1,2 In individuals with HTG, fibrate therapy may drastically reduce the incidence of heart attack and death. 3,4 Postprandial hypertriglyceridemia (PHTG) has emerged as a risk factor for atherosclerotic cardiovascular disease (ASCVD). 5–7 Non-fasting lipid profiles are convenient for predicting ASCVD risk and comparable to or even more meaningful than fasting samples. 8,9 Of note, most people only fast for a few hours daily (in the early morning). The postprandial retention of TG-rich residual lipoproteins in the arterial walls may result in the development of atherosclerosis and ASCVD. 6 Therefore, early detection of abnormal PHTG significantly reduces ASCVD occurrence. Serum gamma-glutamyl transferase (GGT) has recently garnered extensive attention because of its role in cardiovascular and metabolic diseases. 10,11 GGT, a glycoprotein present on the surface of the cell membrane, is widely distributed in various organs and cells. It is an enzyme that determines glut -Abstract Truncated-

Aspartate Aminotransferase (AST/GOT) and Alanine Aminotransferase (ALT/GPT) Detection Techniques

Blood AST, ALT and UREA/BUN Level Analysis

Aspartate Aminotransferase and Alanine Aminotransferase Detection on Paper-Based Analytical Devices with Inkjet Printer-Sprayed Reagents

The Research Progress of γ-Glutamyl Transferase in Coronary Heart Disease

Establishment and evaluation of the reference methods of alanine aminotransferase and aspartate aminotransferase

Low-Cost Point-of-Care Monitoring of ALT and AST Is Promising for Faster Decision Making and Diagnosis of Acute Liver Injury

Differential Pulse Voltammetric Determination of Serum Aspartate Amino-Transferase Activity Using DCIP As Redox Mediator at a Gold Micro Electrode

Optimization of methods for aspartate aminotransferase and alanine aminotransferase.

Current trends in electrochemical approaches for liver biomarker detection: a mini-review

"Activation" of macro-AST by pyridoxal-5-phosphate in the assay for aspartate aminotransferase

The Kinetics-Based Electrochemical Determination of Serum Glutamate Pyruvate Transaminase Activity with A Gold Microelectrode

The current state of serum biomarkers of hepatotoxicity

Toward the point-of-care testing of alkaline phosphatase in human serum

Alanine Aminotransferase: A Clinical and Regulatory Tool for Detecting Liver Injury–Past, Present, and Future

Non-ALT Biomarkers for Markedly Abnormal Liver Histology among Chinese Persistently Normal Alanine Aminotransferase-Chronic Hepatitis B Patients.

Aptasensors Are Conjectured as Promising ALT and AST Diagnostic Tools for the Early Diagnosis of Acute Liver Injury

Assessment of Emerging Biomarkers of Liver Injury in Human Subjects

Using a Personal Glucose Meter and Alkaline Phosphatase for Point-of-Care Quantification of Galactose-1-Phosphate Uridyltransferase in Clinical Galactosemia Diagnosis.

Significance of Combined Determination of Five Types of Serum Enzyme in Diagnosis and Differential Diagnosis of Hepatic and Biliary Diseases

Serum Gamma Glutamyltransferase: A Biomarker for Identifying Postprandial Hypertriglyceridemia